Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00180258 · ClinicalTrials.gov registry record · Phase 2
Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure
A Phase 2 study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 2,200
- Enrollment target
NCT00180258: Completed Phase 2 study, sponsored by Boston Scientific Corporation.
NCT00180258 is a Phase 2 study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 2,200 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1554% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00180258, a Phase 2 study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2,200 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether combined mortality and hospitalization in heart failure patients receiving optimal pharmacologic therapy can be reduced by combining optimal pharmacologic therapy and 1) biventricular pacing therapy alone or 2) biventricular pacing with defibrillation.
Interventions
- DEVICE Cardiac Resynchronization Therapy with & without defibrillator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,200 participants |
| Start Date | 2000-01 |
| Est. Completion | 2002-12 |
| Phase | Phase 2 |
What the finished NCT00180258 record still lists
NCT00180258 is an interventional study that assigns participants to a tested intervention. Its 2,200 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1554% higher).
The record links to 0 conditions, and to 1 intervention - of which Cardiac Resynchronization Therapy with & without defibrillator is the first listed.
NCT00180258 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00180258 about?
NCT00180258 is a clinical study titled "Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure". The purpose of this study is to determine whether combined mortality and hospitalization in heart failure patients receiving optimal pharmacologic therapy can be reduced by combining optimal pharmacologic therapy and 1) biventricular pacing therapy alone or 2) biventricular pacing with defibrillatio...
What is the current status of trial NCT00180258?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2,200 participants. The study started on 2000-01. Estimated completion is 2002-12.
What interventions are being tested in trial NCT00180258?
The interventions under investigation include: Cardiac Resynchronization Therapy with & without defibrillator (DEVICE).
Who is sponsoring clinical trial NCT00180258?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00180258's enrollment target sits among peer trials
2,200 8th of 2000 higher than 1,993 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
- NCT06144554 · 2,200 participants
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
- NCT06526988 · 2,200 participants · NA
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
- NCT06682650 · 2,200 participants · NA
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia